23andMe Holding Co. (ME)
NASDAQ · Healthcare
23andMe Holding Co. Income Statement 2024–2025
| Mar 2025 | Mar 2024 | |
|---|---|---|
| Revenues | ||
| Revenue | 189.9M | 219.6M |
| Gross Profit | 100.0M | 99.4M |
| Profitability | ||
| Operating Income | -179.2M | -321.4M |
| EBITDA | -92.2M | 68.2M |
| Net Income | -280.9M | -666.7M |
| Per Share Data | ||
| EPS (diluted) | $-10.88 | $-28.00 |
| Shares Outstanding (dil.) | 26M | 24M |
23andMe Holding Co. Income Statement — FAQ
23andMe Holding Co. (ME) income statement over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ME's income statement history?
The chart and table above show 23andMe Holding Co.'s income statement by year and by quarter, including the growth rate.